Operating profit before amortization: PolyPid Ltd. (PYPD)
PolyPid Ltd. (PYPD) minimizes surgical risks by developing long-acting agents for patient protection. Operating income dynamics confirm this trajectory, where 0.00 determines the current value of the metric. Expenses for the final stages of gel testing are covered by external capital. Automated Israeli plants and reserves of rare polymers guarantee production stability.
%20Operating%20profit%20EBITDA&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_PYPD_-_PolyPid-Ltd._-_Operating-profit-EBITDA "PolyPid - PYPD Profit before deduction of interest, taxes, depreciation and amortization (period 11/23/2025 - 11/10/2026) | 👁️GURU.Markets👁️")
PolyPid - analytical breakdowns and key metrics (PYPD)
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
- earnings and valuation multiples information:
PYPD - Company Net Income|Company Profit Forecast PolyPid Ltd.|PYPD - Price to Earnings Ratio|Price to Expected Earnings Ratio PolyPid Ltd|PYPD - Price/Earnings to Growth Ratio|Company Value to EBITDA PolyPid|PYPD - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months PolyPid|PYPD - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months polypid.com|PYPD - Earnings per share growth in current year|Net earnings per share change forecast for next year PolyPid Ltd.
Summary company analytics:PYPD PolyPid Ltd.
To minimize investment risks, it is critical to track actual cash flow before debt payments and tax obligations. Amid stable demand for the biotechnologies of PolyPid Ltd. (PYPD), the company's operating profit confirms the business's resilience to macroeconomic shocks. The growth of this indicator reflects high asset liquidity and the issuer's ability to generate cash.
Competitors of PolyPid Ltd. (PYPD)
Operating income before deduction of amortization Summit Pharma (SMMT)|MRNA - Profit before payment of interest, taxes and amortization|PCVX (vaxcyte.com) - Operating profit before amortization|TARS: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization CRMD (CorMedix Inc)|MCRB (Seres) - Operating profit EBITDA|Profit before interest, taxes and amortization Spero Pharma SPRO|Operating profit EBITDA SCYX|Operating profit before deduction of amortization an2therapeutics.com ANTX|LakeShore Biopharma - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ITRM (Iterum Therapeutics PLC)|BiomX Ltd - Operating profit EBITDA|Operating income before deduction of amortization Soligenix, Inc. SNGX|60degreespharma.com (SXTP) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization oragenics.com (OGEN)|Profit before payment of interest, taxes and amortization OpGen
